Less than a week after Merck & amp ; Co. yanked its popular Vioxx arthritis drug off the market, the New England Journal of Medicine voiced strong concerns Wednesday about the safety of Pfizer's bestselling Celebrex.
The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & amp ; Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday.
Pfizer Inc. warned doctors on Friday that one of its bestselling painkillers, Bextra, might increase the risk of a
